(株)中京医薬品の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証STD | 医薬品 | 4558/E03289 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/05/15 | 日証協 | 870,600株 | -9.88% | 97,100株 | +280.78% | 704,454株 | -6.27% | 62,300株 | +386.68% |
2020/05/08 | 日証協 | 966,000株 | +0.86% | 25,500株 | -84.77% | 751,553株 | +0.85% | 12,801株 | -91.7% |
2020/05/01 | 日証協 | 957,800株 | +0.66% | 167,400株 | +24% | 745,253株 | +0.59% | 154,300株 | +63.08% |
2020/04/24 | 日証協 | 951,500株 | +3.39% | 135,000株 | -68.62% | 740,853株 | +3.42% | 94,619株 | -60.13% |
2020/04/17 | 日証協 | 920,346株 | +7.11% | 430,200株 | +14.37% | 716,352株 | +11.73% | 237,319株 | -42.22% |
2020/04/10 | 日証協 | 859,246株 | +25.69% | 376,146株 | -35.2% | 641,133株 | +15.74% | 410,700株 | +97.33% |
2020/04/03 | 日証協 | 683,646株 | +14.94% | 580,492株 | +128.54% | 553,934株 | +13.74% | 208,129株 | +206.97% |
2020/03/27 | 日証協 | 594,800株 | -2.19% | 254,000株 | +98.28% | 487,034株 | +1.8% | 67,800株 | -11.37% |
2020/03/19 | 日証協 | 608,100株 | -13.43% | 128,100株 | -45.47% | 478,436株 | -21.19% | 76,500株 | -39.04% |
2020/03/13 | 日証協 | 702,400株 | +2.05% | 234,900株 | -10.31% | 607,039株 | +3.69% | 125,500株 | +25.37% |
2020/03/06 | 日証協 | 688,300株 | -9.04% | 261,900株 | -42.6% | 585,436株 | -15.06% | 100,104株 | -49.81% |
2020/02/28 | 日証協 | 756,746株 | +6.16% | 456,246株 | -33.31% | 689,244株 | +12.17% | 199,454株 | -65.86% |
2020/02/21 | 日証協 | 712,846株 | +104.7% | 684,146株 | +37.96% | 614,452株 | +104.86% | 584,224株 | +58.71% |
2020/02/14 | 日証協 | 348,246株 | +20.04% | 495,892株 | +37.79% | 299,938株 | -2.72% | 368,104株 | +19.86% |
2020/02/07 | 日証協 | 290,100株 | +159.48% | 359,900株 | +291.62% | 308,338株 | +88.57% | 307,120株 | +239.35% |
2020/01/31 | 日証協 | 111,800株 | +165.56% | 91,900株 | -1.61% | 163,516株 | +9.22% | 90,502株 | +68.84% |
2020/01/24 | 日証協 | 42,100株 | +133.89% | 93,400株 | 0% | 149,718株 | -12.45% | 53,601株 | +4366.75% |
2020/01/17 | 日証協 | 18,000株 | 0% | 0株 | -100% | 171,017株 | -0.81% | 1,200株 | -78.18% |
2020/01/10 | 日証協 | 18,000株 | -4.26% | 500株 | -28.57% | 172,417株 | +1.95% | 5,500株 | +161.9% |
※株式分割は考慮していませんのでご注意ください。
Page Top